HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Role of Inflammation and the Immune System in Diabetes

Chronic inflammation plays a critical role in the onset and progression of diabetes, highlighting the role of inflammation and the immune system in diabetes. In type 1 diabetes, autoimmune destruction of pancreatic beta cells results from dysregulated immune responses, while in type 2 diabetes, low-grade systemic inflammation contributes to insulin resistance. Pro-inflammatory cytokines such as TNF-α and IL-6 disrupt insulin signaling pathways, exacerbating metabolic dysfunction. Emerging therapies targeting inflammatory pathways, including immune-modulating drugs and anti-inflammatory diets, offer new possibilities for intervention. Research continues to explore how immune modulation can delay disease onset and improve long-term outcomes in diabetes management.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp